SlideShare a Scribd company logo
SEVERE ACUTE RESPIRATORY
SYNDROME
SUBJECT: COMMUNITY HEALTH NURSING
PREPARED BY BRIJESH ROHIT
(SECOND YEAR B.SC NURSING)
SIGMA INSTITUTEOF NURSING
Introduction
• There are many communicable diseases that may cause due to
bacteria, virus or fungus.
• Some of the diseases exist throughout the year in the
community where as some diseases outbreaks in a particular
period and threatens the community.
• SARS is the one such a disease which draw the attention of the
world in the year 2002-2003.
• Like the COVID-19, SARS is also caused due to a type of
coronavirus, called the SARS coronavirus (SARS-CoV or SARS-
CoV-1).
Defining the disease
• SARS is a viral respiratory disease of zoonotic origin caused
by SARS-CoV or SARS-CoV-1 virus, the first identified strain
of SARS coronavirus.
• SARS stands for Severe Acute Respiratory Syndrome.
• What is Syndrome?
According to Webster’s dictionary, syndrome is a group of
sign and symptoms that occur together and characterize a
particular disease or illness.
History and magnitude of the problem
• The disease triggered 2002–2004 SARS outbreak, which was
epidemic.
• The first case was traced to a health worker in China in late
2002,with rapid spread in Hong Kong, Singapore and Vietnam.
• In May 2005 the disease itself was declared eradicated by the
‘WHO’ as no cases have been reported worldwide since 2004.
• As of 2020, SARS-CoV-1 virus is considered eradicated in
humans. But as the virus also infects the animals it is possible
that it will re-emerged in the future.
Epidemiological triad
Agent Factor
Host Factor Environmental
Factor
(1) Agent factor(Biological agent)
• The causative agent is SARS-CoV or SARS-CoV-1, which is the
first strain of SARS-CoV.
• SARS-CoV species of coronavirus infects the humans, bats and
other mammals.
• It is enveloped and single stranded RNA virus.
• The SARS virus can survive for hours on common surfaces
outside the human body and 24 hours in human waste. The
virus can also survive at least for 24 hours on a plastic surface
at room temperature.
Electron micrographic image of SARS
coronavirus.
Source of infection
• The source of infection in most cases, is man himself who has
the diseases. He may be case or carrier.
• Through studies after the SARS outbreak, it was found that
bats are the major source of the coronavirus. And it was also
found that the virus jumped to humans through a intermediate
host which is turn out to be Asian palm civets.
(2) Host factor
• Age: Children are rarely affected by SARS. Most commonly in
adults and aged.
• Sex: Both sexes are equally affected.
(3) Environmental factor
SARS can occur in any season in crowdy areas and unhygienic
conditions are the high risk factors where it can spread easily.
➢ Incubation Period:
The incubation period for SARS is about for 4-6 days.
Mode of transmission (Chart)
Clinical manifestations (Flash Cards)
Diagnostic tests
(1) Molecular tests (RT-PCR):
Reverse transcription polymerase chain reaction (RT-PCR) is a lab technique combining
reverse transcription of RNA to DNA and amplification of specific DNA using
polymerase chain reaction (PCR).
Steps:
1. Sample is collected from the patient. After collection, the sample is sealed in a
tube and then sent to laboratory.
2. When a laboratory receives the sample, they perform a process called extraction,
which isolates genetic material from the sample including genetic material from
the virus if present.
3. Then special chemicals and a PCR machine called thermal cycler,
which makes millions of copies of the genetic material. During this
process, one of the chemical produces a fluorescent light if SARS-CoV-1 is
present in the sample. This fluorescent light is a "signal" that is detected
by the PCR machine and special software is used to interpret the signal
as a positive result.
• Positive PCR results mean that there is genetic material (RNA) of the
SARS-CoV is present in the sample and this does not prove that there is
live virus present or that there is present in a quantity large enough to
infect another person.
• Negative PCR results show that the patient is not infected with the
SARS coronavirus.
(2) Antibody test
The test detect antibodies produced in response to the SARS
coronavirus infection. Different types of antibodies (IgM and IgG)
appear and change in level during the course of infection.
ELISA (Enzyme Linked ImmunoSorbant Assay): A test detecting a
mixture of IgG and IgM antibodies in the serum of SARS patients yield
positive results reliably at around day 21 after the onset of illness.
Positive antibody test results indicate infection of SARS-CoV.
Negative antibody test results indicate no detection of antibodies
after 21 days from onset of illness and hence indicate that no
infection with SARS-CoV took place.
(3) Cell culture
Virus in specimens (such as respiratory secretions, blood or stool) from
SARS patients can also be detected by inoculating cell cultures and
growing the virus. Once isolated, the virus must be identified as the
SARS virus with further tests. Cell culture is a very demanding test, but
currently (with the exception of animal trials) only means to show the
existence of a live virus.
Positive cell culture results indicate the presence of live SARS-CoV in
the sample tested.
Negative cell culture results do not exclude SARS but indicate that no
live virus is present in the collected sample for test.
Treatment
There is no specific treatment for SARS.
Antiviral medications and steroids are sometimes
given to reduce lung swelling but are not effective for
everyone.
Supportive care such as supplement oxygen or
ventilation may be prescribed if necessary.
In severe cases, blood plasma from someone
who has already recovered from SARS may also be
administered. However, there is not yet enough
evidence to prove that these treatment are effective.
Preventive
Measures
Because there is no confirmed treatment
or cure for SARS, it is important to take as
many preventive measures as possible.
The preventive measures for SARS control
are early detection and protective
measures that includes:
1. Prompt identifications of persons
infected with SARS, their movement
and contacts.
2. Effective isolation of SARS patients in
hospitals.
3. Appropriate protection of medical
staff treating this patients.
Preventive measures(Continued)
4. Screening of international travelers in the airports and
shipping ports.
5. Timely and accurate reporting and sharing of information with
government and other authorities.
Nursing
Management
• Isolation of suspected cases.
• Barrier nursing with personal protective
equipment.
• Strict handwashing and avoidance of
touching the eyes, nose and mouth.
• Administer antipyretics and other drugs as
per prescription.
• Keep ready ventilators for emergency use.
➢ Health Education:
• Education regarding preventive measures.
• Advice to hold handkerchief
while sneezing or coughing.
• Advice about sanitary measures.
• Educate about high nutrition.
Conclusion
From SARS to COVID-19: What lessons have we learned?
The emergence of SARS-CoV-1 and SARS-CoV-2 suggests that
coronavirus will pose a lasting threat to humans and that the
current epidemic will eventually be brought under control. The
collective memory of SARS and SARS-CoV-2 may gradually fade
but we must not forget the lessons learned from the SARS and
current COVID-19 outbreak.
At the same time, nations and communities need to work
together to fight such outbreak to shorten hospital stays and
reduce the consumption of healthcare resources and we must
prepare for the next pandemic.
Thank You!

More Related Content

What's hot

Plague
PlaguePlague
Infleunza
InfleunzaInfleunza
Severe acute respiratory syndrome (SARS)
Severe acute respiratory syndrome (SARS)Severe acute respiratory syndrome (SARS)
Severe acute respiratory syndrome (SARS)
Dr Shubhangi (Kshirsagar) Hedau
 
Influenza
InfluenzaInfluenza
Influenza
Omkumar Patel
 
Zika virus
Zika virusZika virus
Zika virus
Wal
 
HIV
HIVHIV
Corona virus
Corona virusCorona virus
Corona virus
Hassam Ahmad
 
Sars lec
Sars lecSars lec
Covid vaccines
Covid vaccinesCovid vaccines
Covid vaccines
Immanuel Joshua
 
Ebola virus ppt
Ebola virus pptEbola virus ppt
Ebola virus ppt
Deepak Sarangi
 
SARS clinical features treatment and complications
SARS clinical features treatment and complicationsSARS clinical features treatment and complications
SARS clinical features treatment and complications
prasanna lakshmi sangineni
 
COVID 19
COVID 19  COVID 19
COVID 19
Gamal Agmy
 
Small pox
Small poxSmall pox
Covid 19
Covid   19Covid   19
Covid 19
Shivani Gorasia
 
Yellow fever virus
Yellow fever virusYellow fever virus
Yellow fever virus
Creative-Diagnostics
 
Ebola virus disease
Ebola virus diseaseEbola virus disease
Ebola virus disease
Madhuka Perera
 
Influenza virus-Flu
Influenza virus-FluInfluenza virus-Flu
Influenza virus-Flu
Saajida Sultaana
 

What's hot (20)

Plague
PlaguePlague
Plague
 
Infleunza
InfleunzaInfleunza
Infleunza
 
Severe acute respiratory syndrome (SARS)
Severe acute respiratory syndrome (SARS)Severe acute respiratory syndrome (SARS)
Severe acute respiratory syndrome (SARS)
 
Influenza
InfluenzaInfluenza
Influenza
 
Zika virus
Zika virusZika virus
Zika virus
 
HIV
HIVHIV
HIV
 
Corona virus
Corona virusCorona virus
Corona virus
 
Sars
SarsSars
Sars
 
Chicken pox
Chicken poxChicken pox
Chicken pox
 
Sars lec
Sars lecSars lec
Sars lec
 
Covid vaccines
Covid vaccinesCovid vaccines
Covid vaccines
 
Ebola virus ppt
Ebola virus pptEbola virus ppt
Ebola virus ppt
 
SARS clinical features treatment and complications
SARS clinical features treatment and complicationsSARS clinical features treatment and complications
SARS clinical features treatment and complications
 
COVID 19
COVID 19  COVID 19
COVID 19
 
Small pox
Small poxSmall pox
Small pox
 
Covid 19
Covid   19Covid   19
Covid 19
 
Yellow fever virus
Yellow fever virusYellow fever virus
Yellow fever virus
 
Ebola virus disease
Ebola virus diseaseEbola virus disease
Ebola virus disease
 
Sars
SarsSars
Sars
 
Influenza virus-Flu
Influenza virus-FluInfluenza virus-Flu
Influenza virus-Flu
 

Similar to SARS

Sars review
Sars reviewSars review
Sars review
Shivani Gayakwad
 
Coronavirus disease 2019
Coronavirus disease 2019Coronavirus disease 2019
Coronavirus disease 2019
Diksha Sharma
 
COVID 19-De pope.pdf
COVID 19-De pope.pdfCOVID 19-De pope.pdf
COVID 19-De pope.pdf
musayansa
 
infection_control;_covid_19,_herpes_virus_&_hpv[1][1BN].pptx
infection_control;_covid_19,_herpes_virus_&_hpv[1][1BN].pptxinfection_control;_covid_19,_herpes_virus_&_hpv[1][1BN].pptx
infection_control;_covid_19,_herpes_virus_&_hpv[1][1BN].pptx
boaznabiswa
 
Coronavirus by Dr Afuye O.O.
Coronavirus by Dr Afuye O.O.Coronavirus by Dr Afuye O.O.
Coronavirus by Dr Afuye O.O.
Alade Olubunmi
 
Everything we need to know about COVID-19
Everything we need to know about COVID-19Everything we need to know about COVID-19
Everything we need to know about COVID-19
PrincessExtra
 
Covid 19 diagnosis
Covid 19 diagnosisCovid 19 diagnosis
Covid 19 diagnosis
smarajiT12
 
Mers cov
Mers covMers cov
Corona Virus (covid 19) slideshare
Corona Virus (covid 19) slideshare Corona Virus (covid 19) slideshare
Corona Virus (covid 19) slideshare
Alyshabudhothoki
 
Preventive medicine cholera, sars, ebola virus
Preventive medicine cholera, sars, ebola virusPreventive medicine cholera, sars, ebola virus
Preventive medicine cholera, sars, ebola virus
Ashish Chaudhari
 
Corona Virus.pptx Msc. clinical Microbiology
Corona Virus.pptx Msc. clinical MicrobiologyCorona Virus.pptx Msc. clinical Microbiology
Corona Virus.pptx Msc. clinical Microbiology
Manoj Mahato
 
Corona virus...Awareness,Precautions, & Treatments
Corona virus...Awareness,Precautions, & TreatmentsCorona virus...Awareness,Precautions, & Treatments
Corona virus...Awareness,Precautions, & Treatments
Sagheer Ahmed
 
Corona virus
Corona virusCorona virus
Coronavirus
CoronavirusCoronavirus
Covid 19- consideration in Dental Practice
Covid 19- consideration in Dental PracticeCovid 19- consideration in Dental Practice
Covid 19- consideration in Dental Practice
Riya Shah
 
Novel Coronavirus COVID-19
Novel Coronavirus COVID-19Novel Coronavirus COVID-19
Novel Coronavirus COVID-19
Avinandan Jana
 
Dengue Fever.ppt
Dengue Fever.pptDengue Fever.ppt
Dengue Fever.ppt
WaqarAli458508
 
Dengue Fever1.ppt.pptx
Dengue Fever1.ppt.pptxDengue Fever1.ppt.pptx
Dengue Fever1.ppt.pptx
WaqarAli458508
 
Covid 19 presentation
Covid 19 presentationCovid 19 presentation
Covid 19 presentation
Rudraksh coaching classes
 
MERS CoV MOH Guidelines update 2015
MERS CoV MOH Guidelines update 2015MERS CoV MOH Guidelines update 2015
MERS CoV MOH Guidelines update 2015
Mostafa Mahmoud
 

Similar to SARS (20)

Sars review
Sars reviewSars review
Sars review
 
Coronavirus disease 2019
Coronavirus disease 2019Coronavirus disease 2019
Coronavirus disease 2019
 
COVID 19-De pope.pdf
COVID 19-De pope.pdfCOVID 19-De pope.pdf
COVID 19-De pope.pdf
 
infection_control;_covid_19,_herpes_virus_&_hpv[1][1BN].pptx
infection_control;_covid_19,_herpes_virus_&_hpv[1][1BN].pptxinfection_control;_covid_19,_herpes_virus_&_hpv[1][1BN].pptx
infection_control;_covid_19,_herpes_virus_&_hpv[1][1BN].pptx
 
Coronavirus by Dr Afuye O.O.
Coronavirus by Dr Afuye O.O.Coronavirus by Dr Afuye O.O.
Coronavirus by Dr Afuye O.O.
 
Everything we need to know about COVID-19
Everything we need to know about COVID-19Everything we need to know about COVID-19
Everything we need to know about COVID-19
 
Covid 19 diagnosis
Covid 19 diagnosisCovid 19 diagnosis
Covid 19 diagnosis
 
Mers cov
Mers covMers cov
Mers cov
 
Corona Virus (covid 19) slideshare
Corona Virus (covid 19) slideshare Corona Virus (covid 19) slideshare
Corona Virus (covid 19) slideshare
 
Preventive medicine cholera, sars, ebola virus
Preventive medicine cholera, sars, ebola virusPreventive medicine cholera, sars, ebola virus
Preventive medicine cholera, sars, ebola virus
 
Corona Virus.pptx Msc. clinical Microbiology
Corona Virus.pptx Msc. clinical MicrobiologyCorona Virus.pptx Msc. clinical Microbiology
Corona Virus.pptx Msc. clinical Microbiology
 
Corona virus...Awareness,Precautions, & Treatments
Corona virus...Awareness,Precautions, & TreatmentsCorona virus...Awareness,Precautions, & Treatments
Corona virus...Awareness,Precautions, & Treatments
 
Corona virus
Corona virusCorona virus
Corona virus
 
Coronavirus
CoronavirusCoronavirus
Coronavirus
 
Covid 19- consideration in Dental Practice
Covid 19- consideration in Dental PracticeCovid 19- consideration in Dental Practice
Covid 19- consideration in Dental Practice
 
Novel Coronavirus COVID-19
Novel Coronavirus COVID-19Novel Coronavirus COVID-19
Novel Coronavirus COVID-19
 
Dengue Fever.ppt
Dengue Fever.pptDengue Fever.ppt
Dengue Fever.ppt
 
Dengue Fever1.ppt.pptx
Dengue Fever1.ppt.pptxDengue Fever1.ppt.pptx
Dengue Fever1.ppt.pptx
 
Covid 19 presentation
Covid 19 presentationCovid 19 presentation
Covid 19 presentation
 
MERS CoV MOH Guidelines update 2015
MERS CoV MOH Guidelines update 2015MERS CoV MOH Guidelines update 2015
MERS CoV MOH Guidelines update 2015
 

Recently uploaded

Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
BhavyaRajput3
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
kaushalkr1407
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Atul Kumar Singh
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
DhatriParmar
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
Peter Windle
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
timhan337
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
GeoBlogs
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
SACHIN R KONDAGURI
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
MIRIAMSALINAS13
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
beazzy04
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
TechSoup
 

Recently uploaded (20)

Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
 

SARS

  • 1. SEVERE ACUTE RESPIRATORY SYNDROME SUBJECT: COMMUNITY HEALTH NURSING PREPARED BY BRIJESH ROHIT (SECOND YEAR B.SC NURSING) SIGMA INSTITUTEOF NURSING
  • 2. Introduction • There are many communicable diseases that may cause due to bacteria, virus or fungus. • Some of the diseases exist throughout the year in the community where as some diseases outbreaks in a particular period and threatens the community. • SARS is the one such a disease which draw the attention of the world in the year 2002-2003. • Like the COVID-19, SARS is also caused due to a type of coronavirus, called the SARS coronavirus (SARS-CoV or SARS- CoV-1).
  • 3. Defining the disease • SARS is a viral respiratory disease of zoonotic origin caused by SARS-CoV or SARS-CoV-1 virus, the first identified strain of SARS coronavirus. • SARS stands for Severe Acute Respiratory Syndrome. • What is Syndrome? According to Webster’s dictionary, syndrome is a group of sign and symptoms that occur together and characterize a particular disease or illness.
  • 4. History and magnitude of the problem • The disease triggered 2002–2004 SARS outbreak, which was epidemic. • The first case was traced to a health worker in China in late 2002,with rapid spread in Hong Kong, Singapore and Vietnam. • In May 2005 the disease itself was declared eradicated by the ‘WHO’ as no cases have been reported worldwide since 2004. • As of 2020, SARS-CoV-1 virus is considered eradicated in humans. But as the virus also infects the animals it is possible that it will re-emerged in the future.
  • 5. Epidemiological triad Agent Factor Host Factor Environmental Factor
  • 6. (1) Agent factor(Biological agent) • The causative agent is SARS-CoV or SARS-CoV-1, which is the first strain of SARS-CoV. • SARS-CoV species of coronavirus infects the humans, bats and other mammals. • It is enveloped and single stranded RNA virus. • The SARS virus can survive for hours on common surfaces outside the human body and 24 hours in human waste. The virus can also survive at least for 24 hours on a plastic surface at room temperature.
  • 7. Electron micrographic image of SARS coronavirus.
  • 8. Source of infection • The source of infection in most cases, is man himself who has the diseases. He may be case or carrier. • Through studies after the SARS outbreak, it was found that bats are the major source of the coronavirus. And it was also found that the virus jumped to humans through a intermediate host which is turn out to be Asian palm civets.
  • 9. (2) Host factor • Age: Children are rarely affected by SARS. Most commonly in adults and aged. • Sex: Both sexes are equally affected.
  • 10. (3) Environmental factor SARS can occur in any season in crowdy areas and unhygienic conditions are the high risk factors where it can spread easily. ➢ Incubation Period: The incubation period for SARS is about for 4-6 days.
  • 11. Mode of transmission (Chart) Clinical manifestations (Flash Cards)
  • 12. Diagnostic tests (1) Molecular tests (RT-PCR): Reverse transcription polymerase chain reaction (RT-PCR) is a lab technique combining reverse transcription of RNA to DNA and amplification of specific DNA using polymerase chain reaction (PCR). Steps: 1. Sample is collected from the patient. After collection, the sample is sealed in a tube and then sent to laboratory. 2. When a laboratory receives the sample, they perform a process called extraction, which isolates genetic material from the sample including genetic material from the virus if present.
  • 13. 3. Then special chemicals and a PCR machine called thermal cycler, which makes millions of copies of the genetic material. During this process, one of the chemical produces a fluorescent light if SARS-CoV-1 is present in the sample. This fluorescent light is a "signal" that is detected by the PCR machine and special software is used to interpret the signal as a positive result. • Positive PCR results mean that there is genetic material (RNA) of the SARS-CoV is present in the sample and this does not prove that there is live virus present or that there is present in a quantity large enough to infect another person. • Negative PCR results show that the patient is not infected with the SARS coronavirus.
  • 14. (2) Antibody test The test detect antibodies produced in response to the SARS coronavirus infection. Different types of antibodies (IgM and IgG) appear and change in level during the course of infection. ELISA (Enzyme Linked ImmunoSorbant Assay): A test detecting a mixture of IgG and IgM antibodies in the serum of SARS patients yield positive results reliably at around day 21 after the onset of illness. Positive antibody test results indicate infection of SARS-CoV. Negative antibody test results indicate no detection of antibodies after 21 days from onset of illness and hence indicate that no infection with SARS-CoV took place.
  • 15. (3) Cell culture Virus in specimens (such as respiratory secretions, blood or stool) from SARS patients can also be detected by inoculating cell cultures and growing the virus. Once isolated, the virus must be identified as the SARS virus with further tests. Cell culture is a very demanding test, but currently (with the exception of animal trials) only means to show the existence of a live virus. Positive cell culture results indicate the presence of live SARS-CoV in the sample tested. Negative cell culture results do not exclude SARS but indicate that no live virus is present in the collected sample for test.
  • 16. Treatment There is no specific treatment for SARS. Antiviral medications and steroids are sometimes given to reduce lung swelling but are not effective for everyone. Supportive care such as supplement oxygen or ventilation may be prescribed if necessary. In severe cases, blood plasma from someone who has already recovered from SARS may also be administered. However, there is not yet enough evidence to prove that these treatment are effective.
  • 17. Preventive Measures Because there is no confirmed treatment or cure for SARS, it is important to take as many preventive measures as possible. The preventive measures for SARS control are early detection and protective measures that includes: 1. Prompt identifications of persons infected with SARS, their movement and contacts. 2. Effective isolation of SARS patients in hospitals. 3. Appropriate protection of medical staff treating this patients.
  • 18. Preventive measures(Continued) 4. Screening of international travelers in the airports and shipping ports. 5. Timely and accurate reporting and sharing of information with government and other authorities.
  • 19. Nursing Management • Isolation of suspected cases. • Barrier nursing with personal protective equipment. • Strict handwashing and avoidance of touching the eyes, nose and mouth. • Administer antipyretics and other drugs as per prescription. • Keep ready ventilators for emergency use. ➢ Health Education: • Education regarding preventive measures. • Advice to hold handkerchief while sneezing or coughing. • Advice about sanitary measures. • Educate about high nutrition.
  • 20. Conclusion From SARS to COVID-19: What lessons have we learned? The emergence of SARS-CoV-1 and SARS-CoV-2 suggests that coronavirus will pose a lasting threat to humans and that the current epidemic will eventually be brought under control. The collective memory of SARS and SARS-CoV-2 may gradually fade but we must not forget the lessons learned from the SARS and current COVID-19 outbreak. At the same time, nations and communities need to work together to fight such outbreak to shorten hospital stays and reduce the consumption of healthcare resources and we must prepare for the next pandemic.